Certified by Founder Lodge
TCGX
United States - Palo Alto, California
INVESTOR
1 Disclosed Funding Rounds $200,000,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
TCGX is a registered investment advisor based in Palo Alto, California. We work closely with The Column Group, a leading venture capital firm focused on building innovative drug discovery com
| Company | Date | Round | Raised |
|---|---|---|---|
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Mirador Therapeutics |
March, 26 ,2024 | Unknown | $400,000,000 |
 Pheon Therapeutics |
May, 21 ,2024 | Series B | $120,000,000 |
 Beacon Therapeutics |
July, 10 ,2024 | Series B | $170,000,000 |
 Candid Therapeutics |
September, 10 ,2024 | Unknown | $370,000,000 |
 Vicebio |
September, 24 ,2024 | Series B | $100,000,000 |
 Adcendo |
November, 26 ,2024 | Series B | $135,000,000 |
 Aviceda Therapeutics |
January, 08 ,2025 | Series C | $207,500,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
